Viewing nowCombinationEshuva 10/10 mg (Ezetimibe, Rosuvastatin)
Ezetimibe 10mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.

MFDS item code 201601202 · Approved 2016.02.29 · Insurance code 670607460
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medicine helps lower high total cholesterol and LDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, as well as decrease Apo B protein, triglycerides, and non-HDL cholesterol, while increasing good cholesterol HDL cholesterol. It is primarily used as an adjunct to dietary therapy, and it is especially important to take it along with a diet that limits saturated fats and cholesterol intake. This medication should be used with caution in patients at high risk of atherosclerotic vascular disease, and other underlying conditions or the effects of medications should be assessed and treated as necessary. Additionally, blood lipid levels should be accurately measured before and after treatment to monitor the progress. This drug is used to reduce the risk of atherosclerosis through the treatment of dyslipidemia and to improve cardiovascular health.
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended starting dose is 10/5mg once daily. For patients who require a greater reduction in LDL cholesterol, the dose may be adjusted. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose should be adjusted accordingly; it may be increased up to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication poses a risk of muscle-related issues, so if severe muscle pain or weakness occurs, consult a doctor immediately. In particular, in cases of severe infections, hypotension, major surgery, trauma, or serious endocrine and electrolyte disturbances, it may be necessary to temporarily stop or discontinue using this drug. It should not be used in patients with allergies to any of its components or with liver disease, muscle disease, or severe renal impairment. Women who are pregnant or possibly pregnant, or nursing mothers should also avoid using this medication. Caution must be exercised when using this drug in patients with alcohol dependence or poor liver function, elderly patients, those with hypothyroidism, or with a history of genetic muscle disorders. This medication contains lactose, so patients with lactose intolerance should refrain from taking it. During treatment, liver function and muscle condition should be monitored regularly, and immediate medical attention should be sought if liver enzyme levels are abnormally high or if severe muscle pain occurs. There should be caution regarding drug interactions when taking other medications, especially when used together with certain antibiotics, antifungals, immunosuppressants, and fibrate medications, as the risk of muscle abnormalities may increase. During pregnancy, it can be harmful to the fetus, so contraception must be ensured, and if pregnancy is confirmed, intake should be immediately discontinued. Safety in children or adolescents has not been fully established and is not recommended. In the case of overdose, there is no specific antidote, so appropriate treatment should be received based on symptoms, and liver function and muscle condition should be monitored. This drug should be kept out of the reach of children and not stored in another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering, and the storage temperature should be kept between 1°C and 30°C (room temperature). Storing it this way can help maintain the drug's efficacy.
Yellow oval film-coated tablet
30 tablets (10 tablets PTP x 3), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogene Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.